cdmo.directory
← Compare landing

重庆兴泰濠制药有限公司 (Sintaho) vs Winkem Labs Pvt. Ltd.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

Category重庆兴泰濠制药有限公司 (Sintaho)Winkem Labs Pvt. Ltd.
SummaryChina-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.Contract development and manufacturing organization (CDMO) offering complex chemical synthesis, process development, API manufacturing, and supply services for pharmaceutical clients globally.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Peptide Manufacturing
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Peptide
  • Small Molecule
Development capabilitiesData not yet provided.
  • Analytical method development
Manufacturing capabilities
  • Drug Substance (DS)
  • HPAPI
  • Drug Substance (DS)
  • Drug Product (DP)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Stainless Steel
  • Max chemical: Commercial (>100 kg / tonne)
  • HPAPI
  • Cryogenic (−80 °C)
Locations
  • Headquarters, Chongqing, Chongqing, China
  • Registered Office, Hyderabad, Telangana, India
Certifications
  • Internet Drug Information Service Qualification (Chongqing) · Identifier: (渝)-非经营性-2022-0020
Data not yet provided.

Find similar companies

重庆兴泰濠制药有限公司 (Sintaho) alternatives · Winkem Labs Pvt. Ltd. alternatives

Markdown mirror: /compare/sintaho/winkemlabs.md